Scarica l'app Stockscreener
13.16
8.09%
-1.17
Precedente Chiudi:
$14.33
Aprire:
$13.2
Volume 24 ore:
2.85M
Relative Volume:
1.75
Capitalizzazione di mercato:
$1.63B
Reddito:
-
Utile/perdita netta:
$-115.88M
Rapporto P/E:
-8.5079
EPS:
-1.5468
Flusso di cassa netto:
$-104.72M
1 W Prestazione:
-8.98%
1M Prestazione:
-7.32%
6M Prestazione:
-55.60%
1 anno Prestazione:
-24.66%
Intervallo 1D:
$12.15
$13.50
Intervallo di 1 settimana:
$12.15
$14.85
Portata 52W:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Nome
Edgewise Therapeutics Inc
Settore
Industria
Telefono
720-262-7002
Indirizzo
1715 38TH ST, BOULDER
Confronta EWTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
13.16 | 1.63B | 0 | -115.88M | -104.72M | -1.5468 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.00 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
522.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.64 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.23 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
256.42 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-30 | Iniziato | Guggenheim | Buy |
| 2025-04-02 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-01-22 | Iniziato | Stifel | Hold |
| 2024-11-22 | Iniziato | Evercore ISI | Outperform |
| 2024-03-07 | Iniziato | Piper Sandler | Overweight |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2022-08-25 | Downgrade | Goldman | Neutral → Sell |
| 2022-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-01-28 | Iniziato | Goldman | Neutral |
Mostra tutto
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.8%Here's What Happened - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stake Boosted by GAMMA Investing LLC - MarketBeat
Rhumbline Advisers Purchases 6,440 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $39.78 Average PT from Analysts - MarketBeat
Enliven to sell $200M in stock after positive drug trial - BizWest
Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect? - MSN
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Transcript : Edgewise Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03 - MarketScreener
Bank of America Corp DE Has $1.31 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Receives "Outperform" Rating from Royal Bank of Canada - MarketBeat
Ameriprise Financial Inc. Purchases Shares of 22,584 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Royal Bank of Canada Reaffirms Outperform Rating for Edgewise Therapeutics (NASDAQ:EWTX) - Defense World
Bank of America Corp DE Decreases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Edgewise Therapeutics (EWTX) Receives Reaffirmed 'Outperform' Ra - GuruFocus
RBC Capital maintains outperform rating on Edgewise Therapeutics stock By Investing.com - Investing.com India
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Invests $2.40 Million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics to Present at the Annual Goldman Sachs Global Healthcare Conference - Eastern Progress
Muscle Disease Leader Edgewise Therapeutics Set for Key Goldman Sachs Healthcare Conference Presentation - Stock Titan
Two Sigma Investments LP Has $3.52 Million Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Certain Stock Options of Edgewise Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-JUN-2025. - marketscreener.com
Certain Common Stock of Edgewise Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-JUN-2025. - marketscreener.com
(EWTX) Technical Data - news.stocktradersdaily.com
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Nuveen Asset Management LLC - MarketBeat
Polar Asset Management Partners Inc. Has $1.72 Million Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics: Upcoming DMD Trial Data May Disappoint (NASDAQ:EWTX) - Seeking Alpha
Nuveen Asset Management LLC Acquires 158,452 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Woodline Partners LP Has $15.15 Million Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 174% Potential Upside in Biotech - DirectorsTalk Interviews
BNP Paribas Financial Markets Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
106,562 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Purchased by Point72 Asset Management L.P. - MarketBeat
Frazier Life Sciences Management L.P. Cuts Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics’ SWOT analysis: promising rare disease pipeline faces challenges By Investing.com - Investing.com South Africa
Edgewise Therapeutics’ SWOT analysis: promising rare disease pipeline faces challenges - Investing.com India
Polar Asset Management Partners Inc. Trims Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Tang Capital Management LLC Takes Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Deutsche Bank AG Grows Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
How to Take Advantage of moves in (EWTX) - news.stocktradersdaily.com
Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Edgewise Therapeutics Inc Azioni (EWTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Russell Alan J | Chief Scientific Officer |
May 02 '25 |
Sale |
16.45 |
1,551 |
25,520 |
18,521 |
| MOORE JOHN R | General Counsel |
May 01 '25 |
Option Exercise |
0.00 |
5,209 |
0 |
8,461 |
| MOORE JOHN R | General Counsel |
May 02 '25 |
Sale |
16.45 |
1,930 |
31,757 |
6,531 |
| KOCH KEVIN | President and CEO |
May 01 '25 |
Option Exercise |
0.00 |
10,417 |
0 |
24,895 |
| KOCH KEVIN | President and CEO |
May 02 '25 |
Sale |
16.45 |
4,276 |
70,358 |
20,619 |
| Donovan Joanne M. | CMO |
May 01 '25 |
Option Exercise |
0.00 |
10,417 |
0 |
26,775 |
| Donovan Joanne M. | CMO |
May 02 '25 |
Sale |
16.45 |
5,187 |
85,348 |
21,588 |
| Derakhshan Behrad | Chief Business Officer |
May 01 '25 |
Option Exercise |
0.00 |
5,209 |
0 |
22,046 |
| Derakhshan Behrad | Chief Business Officer |
May 02 '25 |
Sale |
16.45 |
1,691 |
27,824 |
20,355 |
| Carruthers R Michael | Chief Financial Officer |
May 01 '25 |
Option Exercise |
0.00 |
5,209 |
0 |
82,328 |
0.78%
1.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):